Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis

NCT01216280 is registered in ClinicalTrials.gov with Natrogen Therapeutics International, Inc as lead sponsor.

NCT NCT01216280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01216280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis
Lead sponsor
Natrogen Therapeutics International, Inc
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2010
Completion date
September 30, 2011
Enrollment
75 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis